@FlippoFlip Wie würde dieser Graph aussehen, wenn dieser 20 Jahre früher beginnen würde?

@energisch_ I've not the slightest idea whether it's even possible to buy enough in advance to provide currently treated and any surplus which may come on top after diagnosis. Especially in light of rising infection rates globally due to war and other socioeconomic factors. What's definitely at risk are treatment options. One does not tolerate each available regimen and some got resistant virus in their DNA, so already have limited options. Need production long term.

@EUCommission @bert_hubert

@energisch_ @bert_hubert yes, for instance there are international, US based pharma groups delivering vital HIV medication (as in treatment for HIV positive as well as preventative drugs for HIV negative people) to the world.

If these would be to retreat from European markets it could cripple TasP and prevention efforts.

https://en.wikipedia.org/wiki/AbbVie

https://en.wikipedia.org/wiki/Bristol_Myers_Squibb

https://en.wikipedia.org/wiki/Johnson_%26_Johnson

https://en.wikipedia.org/wiki/Gilead_Sciences

https://en.wikipedia.org/wiki/Merck_%26_Co.

https://en.wikipedia.org/wiki/Viatris

#actupagain #aids #hiv

ADHS-Medikamente erhöhen Wachheit und Belohnung
https://www.pharmazeutische-zeitung.de/adhs-medikamente-erhoehen-wachheit-und-belohnung-161530/

#adhs #Stimulanzien